Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Sophie Vitesnik"'
Autor:
Jeff Butler, Kathryn A Hooper, Stephen Petrie, Raphael Lee, Sebastian Maurer-Stroh, Lucia Reh, Teagan Guarnaccia, Chantal Baas, Lumin Xue, Sophie Vitesnik, Sook-Kwan Leang, Jodie McVernon, Anne Kelso, Ian G Barr, James M McCaw, Jesse D Bloom, Aeron C Hurt
Publikováno v:
PLoS Pathogens, Vol 10, Iss 4, p e1004065 (2014)
Oseltamivir is relied upon worldwide as the drug of choice for the treatment of human influenza infection. Surveillance for oseltamivir resistance is routinely performed to ensure the ongoing efficacy of oseltamivir against circulating viruses. Since
Externí odkaz:
https://doaj.org/article/880cbfe29e8947399fd00b5a6fda714d
Autor:
Rubaiyea Farrukee, Jacqueline Panozzo, Sophie Vitesnik, David Piedrafita, Ding Yuan Oh, Jennifer Mosse, Aeron C. Hurt
Publikováno v:
Antiviral Therapy. 23:295-306
Background Intravenous zanamivir has been used to treat patients with severe influenza. Because the majority of cases (including immunocompromised patients) require the drug for an extended period of treatment, there is a higher risk that the virus w
Autor:
Kathryn A. Hooper, James M. McCaw, Jeff Butler, Lumin Xue, Ian G. Barr, Aeron C. Hurt, Jesse D. Bloom, Lucia Reh, Teagan Guarnaccia, Raphael T.C. Lee, Anne Kelso, Sook Kwan Leang, Chantal Baas, Stephen Petrie, Sebastian Maurer-Stroh, Jodie McVernon, Sophie Vitesnik
Publikováno v:
PLoS Pathogens, Vol 10, Iss 4, p e1004065 (2014)
PLoS Pathogens
PLoS Pathogens
Oseltamivir is relied upon worldwide as the drug of choice for the treatment of human influenza infection. Surveillance for oseltamivir resistance is routinely performed to ensure the ongoing efficacy of oseltamivir against circulating viruses. Since